News Releases

April 13, 2021 at 7:51 AM EDT

Summary Toggle OptimizeRx Named to Financial Times ―The Americas’ Fastest-Growing Companies List for the Second Consecutive Year

Ranked #277, highlighting the growth potential and convergence between technology and healthcare ROCHESTER, Mich. , April 13, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received

PDF Version
March 16, 2021 at 7:30 AM EDT

Summary Toggle OptimizeRx Recurring Revenue Grows as it Secures 19 New Enterprise-Level Engagements in Q1 2021

ROCHESTER, Mich. , March 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has secured 19 new enterprise-level deals for 2021 that provide access to the company’s full suite of solutions

PDF Version
March 3, 2021 at 7:31 AM EST

Summary Toggle OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021

ROCHESTER, Mich. , March 03, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the 33 rd Annual ROTH Growth Conference being held virtually on March 15-17, 2021

PDF Version
February 24, 2021 at 4:01 PM EST

Summary Toggle OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share

ROCHESTER, Mich. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the fourth quarter and full year ended December 31, 2020 .

PDF Version
February 23, 2021 at 7:31 AM EST

Summary Toggle OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List

List Celebrates Accomplished Young Talent in Medical Marketing ROCHESTER, Mich. , Feb. 23, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its senior vice president and

PDF Version
February 18, 2021 at 7:31 AM EST

Summary Toggle OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET

ROCHESTER, Mich. , Feb. 18, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Wednesday, February 24, 2021 at 4:30 p.m.

PDF Version
February 16, 2021 at 7:31 AM EST

Summary Toggle OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021

ROCHESTER, Mich. , Feb. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the SVB Leerink 10 th Annual Global Healthcare Conference being held

PDF Version
February 9, 2021 at 9:10 AM EST

Summary Toggle OptimizeRx Announces Pricing of Public Offering of Common Stock

ROCHESTER, Mich. , Feb. 09, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patients, today announced the pricing of the previously announced underwritten public offering of

PDF Version
February 8, 2021 at 4:17 PM EST

Summary Toggle OptimizeRx Announces Proposed Public Offering of Common Stock

ROCHESTER, Mich. , Feb. 08, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patients, today announced it has commenced an underwritten public offering of shares of its common

PDF Version
January 25, 2021 at 7:31 AM EST

Summary Toggle OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million

ROCHESTER, Mich. , Jan. 25, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020 .

PDF Version